Regulatory T cells (T~reg~ cells) play key roles in protecting against autoimmune responses to tissues, preventing inappropriate responses to commensal organisms and dampening effector T cell responses following clearance of pathogens. However, the mechanisms that lead to the development of a population of Treg cells that can mediate such diverse functions remain unclear. T~reg~ cells were shown to develop through a two-step process in the thymus ^[@R1],\ [@R2]^. The first step is driven by strong signals sent through the T cell antigen receptor (TCR), which leads to upregulation of CD25, the key component of the high-affinity receptor for IL-2, as well as the TNF receptor superfamily members GITR, OX40 and TNFR2, but not the upregulation of the transcription factor Foxp3 ^[@R1],\ [@R3]^. A second, TCR-independent, step involves the conversion of the CD25^+^ T~reg~P cells into mature CD25^+^Foxp3^+^ T~reg~ cells in a manner dependent on the cytokine IL-2 and the transcription factor STAT5 ^[@R1],\ [@R2],\ [@R4],\ [@R5]^. A distinct T~reg~ cell progenitor population, characterized by low expression of Foxp3 and lacking detectable expression of CD25, was also described in the thymus ^[@R6]^. This Foxp3^lo^ T~reg~P cell has high expression of GITR and OX40 ^[@R3]^, and can differentiate into mature CD25^+^Foxp3^+^ T~reg~ cells following stimulation with IL-2 ^[@R6]^. The relative contributions of these T~reg~P cell populations to the mature T~reg~ cell pool remains controversial.

Here we demonstrate that CD25^+^Foxp3^−^ T~reg~ cell progenitors (CD25^+^ T~reg~P hereafter) and CD25^−^Foxp3^lo^ T~reg~ progenitors (Foxp3^lo^ T~reg~P hereafter) generated mature T~reg~ cells with relatively comparable efficiency in vitro and in vivo. The two developmental pathways for T~reg~ cell generation differed in many aspects, including distinct transcriptomes and TCR repertoires. The CD25^+^ T~reg~P exhibited increased apoptosis, developed into mature T~reg~ cells with faster kinetics and exhibited greater reactivity with self-antigens in the thymus than Foxp3^lo^ T~reg~P. Development of the two T~reg~ cell progenitor subsets was controlled by different cytokines, signaling pathways, gene enhancers and stromal cells in the thymus. Finally, T~reg~ cells derived from CD25^+^ T~reg~P, but not Foxp3^lo^ T~reg~P, protected against experimental autoimmune encephalomyelitis. Our data suggest a model in which two distinct T~reg~ cell progenitor subsets both contribute to generate a broad T~reg~ cell repertoire able to protect against immune responses to self-antigen, limit immune responses to commensal organisms and resolve immune responses to foreign pathogens.

Results {#S1}
=======

CD25^+^ and Foxp3^lo^ T~reg~P cells differentiate into T~reg~ cells {#S2}
-------------------------------------------------------------------

To determine if CD25^+^ and Foxp3^lo^ T~reg~P are both bona-fide thymic T~reg~ progenitors we compared their ability to convert into mature T~reg~ cells in response to low doses of IL-2 for 3 days *in vitro*. Sorted CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P responded to very low amounts of IL-2 (0.2--1.0 U/mL) by converting to mature CD25^+^Foxp3^+^ T~reg~ cells ([Supplementary Fig. 1a](#SD2){ref-type="supplementary-material"}) indicating that although they lack CD25 expression, Foxp3^lo^ T~reg~P, which express the low affinity IL-2R, consisting of the IL-2Rβ and IL-2Rγ chains, were responsive to IL-2. Mature CD25^+^Foxp3^+^ T~reg~ cells exhibited even greater sensitivity to IL-2, as they maintained their phenotype and viability at concentrations of IL-2 (0.04 U/mL) to which CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells did not respond ([Supplementary Fig. 1a](#SD2){ref-type="supplementary-material"}). To confirm these findings *in vivo*, we used ultrasound-guided intrathymic injection to co-transfer sorted congenically distinct (CD90.2^+^CD45.2^+^ or CD90.1^+^CD45.2^+^) CD25^+^ or Foxp3^lo^ T~reg~P cells into the thymi of CD45.1^+^ mice ([Fig. 1b](#F1){ref-type="fig"}, [Supplementary Fig. 1b](#SD2){ref-type="supplementary-material"}). Six days post-injection, total congenically labelled cells, derived from CD25^+^ or Foxp3^lo^ T~reg~P, were recovered from the host thymi with similar efficiency (data not shown). CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells converted into mature CD25^+^Foxp3^+^ T~reg~ cells with approximately the same frequency, although CD25^+^ T~reg~P did so slightly better (\~45±16.9% to 37±23.5%, respectively; [Fig. 1b](#F1){ref-type="fig"}). Thus, both CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P contributed to the generation of mature T~reg~ cells with high efficiency in vitro and in vivo.

CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells have distinct TCR repertoires {#S3}
-------------------------------------------------------------------------

To address whether the CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells represent distinct subsets of cells with different TCR repertoires, or whether the T~reg~ cell developmental pathway chosen only reflects the stochastic expression of CD25 or Foxp3, we used mice expressing a fixed TCliβ *TCRb* transgene on a *TCRa*^*+/−*^ heterozygous background expressing a Foxp3-RFP reporter ^[@R7],\ [@R8],\ [@R9]^. Using these mice we carried out high throughput sequencing of the TCR *Trav14* genes in conventional CD25^−^Foxp3^−^ thymocytes, CD25^+^ T~reg~P, Foxp3^lo^ T~reg~P and mature CD25^+^Foxp3^+^ T~reg~ cells. Consistent with previously published results ^[@R7],\ [@R10],\ [@R11]^, we found little overlap between the *Trav14* repertoire of conventional CD25^−^Foxp3^−^ thymocytes and mature thymic CD25^+^Foxp3^+^ T~reg~ cells ([Fig. 2a](#F2){ref-type="fig"}). As reported ^[@R1]^, we found substantial overlap between the Trav14 repertoire of CD25^+^ T~reg~P cells and mature CD25^+^Foxp3^+^ T~reg~ cells ([Fig. 2a](#F2){ref-type="fig"},[b](#F2){ref-type="fig"}, [Table 1](#T1){ref-type="table"}). Importantly, the TCR repertoire of the Foxp3^lo^ T~reg~P also overlapped substantially with that of mature CD25^+^Foxp3^+^ T~reg~ cells ([Fig. 2a](#F2){ref-type="fig"}). However, the TCR repertoires of the CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cell populations showed very little overlap, despite their significant individual overlap with the repertoire of mature T~reg~ cells ([Fig. 2a](#F2){ref-type="fig"},[b](#F2){ref-type="fig"}). To narrow our analysis to TCRs that are known to be represented in the mature T~reg~ cell pool, we reanalyzed our TCR repertoire data but this time excluding all the TCRs not detected in the thymic mature T~reg~ cell pool. The ratios of Morisita-Horn indices (T~reg~P to T~reg~P versus T~reg~P to T~reg~ cell) calculated using TCRs detected only in mature CD25^+^Foxp3^+^ T~reg~ cells in the thymus were not significantly different than the ratios obtained when using all TCRs([Supplementary Table 1](#SD5){ref-type="supplementary-material"}). Thus, CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells had distinct TCR repertoires and contributed unique TCR clones to the mature T~reg~ cell repertoire.

CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells have distinct affinity for self-antigen {#S4}
-----------------------------------------------------------------------------------

Next we examined the types of antigens that CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P interacted with. The relative abundance of either T~reg~P cell subset was similar in germ-free mice compared to specific pathogen-free mice ([Supplementary Fig. 2a](#SD2){ref-type="supplementary-material"},[b](#SD2){ref-type="supplementary-material"}) or in C57Bl/6 mice co-housed with pet store mice, which have a normalized microbial experience ^[@R12]^, compared to specific pathogen-free mice ([Supplementary Fig. 2c](#SD2){ref-type="supplementary-material"}), suggesting that interactions with self antigens were the major driver of T~reg~ cell selection in the thymus. We used expression of the transcription factor Nur77, whose abundance is directly proportional to TCR signal strength, to assess the strength of the interaction of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells with self-antigens in the thymus. In Nur77-GFP mice, in which GFP expression correlates with the strength of TCR stimulation ^[@R13],\ [@R14]^, mature CD25^+^Foxp3^+^ T~reg~ cells have higher expression of Nur77-GFP than conventional CD4^+^Foxp3^−^ T cells ^[@R3],\ [@R13],\ [@R14]^, corresponding with the higher degree of self-reactivity attributed to T~reg~ cells ^[@R7]^. In this system, expression of Nur77-GFP in CD25^+^ T~reg~P cells was significantly higher compared to that recorded in mature T~reg~ cells ([Fig. 2c](#F2){ref-type="fig"},[d](#F2){ref-type="fig"}), while the expression of Nur77-GFP in Foxp3^lo^ T~reg~P cells was significantly lower than that of CD25^+^ T~reg~P cells ([Fig. 2c](#F2){ref-type="fig"},[d](#F2){ref-type="fig"}). These findings indicate that CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells have distinct affinities for self-antigens in the thymus.

We next assessed the transcriptomic differences between the T~reg~P subsets using single-cell RNA-Seq. CD25^+^ T~reg~P cells, Foxp3^lo^ T~reg~P cells and mature, CD25^+^Foxp3^+^ T~reg~ cells sorted from thymi of *Foxp3*-GFP mice, in which an IRES-GFP construct was knocked into the3' UTR of the *Foxp3* gene, and were used to create individual single cell RNA-Seq libraries that were subjected to high-throughput sequencing. The transcriptomic data from these individual libraries was then combined for joint analysis. Individual cells were color-coded based on sort origin and a combined dimensional reduction with graph-based clustering approach followed by a shared nearest-neighbor modularity optimization-based clustering algorithm (Seurat R package) was applied to this combined data set to identify cell groups with distinct gene expression. This analysis generated clusters of cells that closely confirmed the original sorted populations ([Fig. 2e](#F2){ref-type="fig"}), based on expression of *Il2ra* and *Foxp3* ([Supplementary Fig. 3a](#SD2){ref-type="supplementary-material"}). The analysis also identified a small subset of contaminating thymocytes that expressed *Rag1*, *Cd8b1* and *Dntt* and therefore likely represent CD4^+^CD8^+^ double positive thymocytes ([Fig. 2f](#F2){ref-type="fig"}). Heat maps based on the top ten most differentially expressed genes for each cell subset discriminated all four cell clusters ([Fig. 2f](#F2){ref-type="fig"}). Analysis of differentially expressed genes indicated that there were \~180 reproducibly differentially expressed genes between CD25^+^ and Foxp3^lo^ T~reg~P cell subsets ([Fig. 2f](#F2){ref-type="fig"} and [Supplementary Table 2](#SD4){ref-type="supplementary-material"}). Similar results were obtained in an independent single-cell RNA-Seq study with individually sorted CD25^+^ T~reg~P cell, Foxp3^lo^ T~reg~P cell and mature T~reg~ cell libraries ([Supplementary Fig. 3b](#SD2){ref-type="supplementary-material"}) or when CD25^+^ T~reg~P, Foxp3^lo^ T~reg~P cells and mature T~reg~ cell subsets were combined into one library (data not shown). CD25^+^ T~reg~P were enriched in pro-apoptotic genes and genes involved in negative selection (*Nr4a1* and *Bcl2l11*) ([Supplementary Fig. 3c](#SD2){ref-type="supplementary-material"}, [Supplementary Table 2](#SD4){ref-type="supplementary-material"}), consistent with stronger TCR signaling in this subset. Foxp3^lo^ T~reg~P had increased expression of *Ms4a4b* and *Ms4a6b* ([Fig. 2f](#F2){ref-type="fig"}), which encode MS4A4B and MS4A6B, which bind to GITR and enhance signaling via TCR and GITR ^[@R15]^ and may facilitate differentiation of lower affinity CD4^+^ thymocytes into Foxp3^lo^ T~reg~P and enhance sensitivity of Foxp3^lo^ T~reg~P to IL-2 ^[@R3]^. Thus, CD25^+^ T~reg~P cells and Foxp3^lo^ T~reg~P cells had distinct interactions with self-antigens presented in the thymus and unique transcriptomes indicative of distinct modes of selection and differentiation.

CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells are at distinct developmental stages {#S5}
--------------------------------------------------------------------------------

The cell surface markers CD24 and Qa2, or CD69 and MHCI, can be used as surrogates to analyze thymocyte age ^[@R16]^. We found that CD25^+^ T~reg~P cells were largely CD24^hi^Qa2^lo^ (87%) and CD69^hi^ MHC1^+^, and thus representative of immature CD4^+^ thymocytes. In contrast, only 38% of Foxp3^lo^ T~reg~P cells were found in the CD24^hi^Qa2^lo^ gate with the remainder being CD24^lo^Qa2^hi^, indicative of a more mature stage of thymocyte development ([Supplementary Fig. 4a](#SD2){ref-type="supplementary-material"},[b](#SD2){ref-type="supplementary-material"}). To examine this issue more precisely, we used *Rag2-*GFP transgenic mice, in which GFP expression is controlled by the *Rag2* gene regulatory elements, to determine the kinetics of differentiation for CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells. The *Rag2-GFP* transgene turns off after positive selection in CD4^+^CD8^+^ thymocytes, after which the GFP protein decays with a relatively slow half-life, allowing GFP^+^ recent thymic emigrants to be distinguished from older GFP^−^ T cells in peripheral blood and lymphoid organs ^[@R17]^. To determine whether within the GFP^+^ thymocyte fraction a gradient in GFP expression could distinguish thymocytes at different stages of development, we gated on CD4^+^RAG2-GFP^+^ thymocytes and examined CD25 and Foxp3 expression in different bins determined by expression of RAG2-GFP. RAG2-GFP^brightest^ cells (bin 1) were all CD25^−^Foxp3^−^ CD4SP thymocytes ([Fig. 3a](#F3){ref-type="fig"}). CD25^+^ T~reg~P, but no Foxp3^lo^ T~reg~P cells or mature CD25^+^Foxp3^+^ T~reg~ cells were detected in bin 2, while Foxp3^lo^ T~reg~P and mature CD25^+^Foxp3^+^ T~reg~ cells appeared in bin 3. CD25^+^ T~reg~P, Foxp3^lo^ T~reg~P and mature CD25^+^Foxp3^+^ T~reg~ cells were all detected in bins 4--6, while CD25^+^ T~reg~P cells were no longer detected in bin 7, as these cells differentiate, die or leave the thymus ([Fig. 3a](#F3){ref-type="fig"} and [Supplementary Video 1](#SD6){ref-type="supplementary-material"}). Bin 8 contained GFP^--^ cells ([Fig. 3a](#F3){ref-type="fig"}), representing fully mature recirculating T cells. This analysis indicated that the CD25^+^ T~reg~P cells differentiated rapidly, while Foxp3^lo^ T~reg~P cells took longer to develop.

About half of CD25^+^Foxp3^+^ T~reg~ cells in the thymus represent mature recirculating cells ^[@R18],\ [@R19]^. Because 18% of Foxp3^lo^ T~reg~P cells consisted of recirculating Rag2-GFP^−^ T cells ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}), we looked for cell surface markers that could distinguish newly developed RAG2-GFP^+^ thymocytes from recirculating RAG2-GFP^−^ T cells. Over 99% of CD73^−^ cells were RAG2-GFP^+^, while \>85% of CD73^+^ cells were RAG2-GFP^−^ ([Fig. 3b](#F3){ref-type="fig"}), suggesting expression of CD73 could distinguish between developing thymocytes and recirculating mature T cells in the thymus in the absence of the *Rag2-GFP* transgenic reporter. To assess whether Foxp3^lo^ T~reg~P cells, which arose with slower kinetics and exhibited reduced TCR signal strength, were more dependent on adhesion molecules like LFA-1, which help prolong T cell-APC contacts and enhance TCR signaling ^[@R20]^, we examined T~reg~ cell development in *Itgal*^*−/−*^ mice, which are LFA-1 deficient. CD73^−^ Foxp3^lo^ T~reg~P, but not CD73^−^ CD25^+^ T~reg~P cells were decreased in *Itgal*^*−/−*^ thymi compared to wild-type thymi ([Fig. 3c](#F3){ref-type="fig"}). Thus, development of Foxp3^lo^ T~reg~P cells was more dependent on stable T cell-APC interactions or LFA-1-dependent co-stimulation compared to CD25^+^ T~reg~P cells.

Based on Foxp3 overexpression studies, Foxp3^lo^ T~reg~P cells were proposed to be very susceptible to apoptosis ^[@R6]^. Because our single cell RNA-Seq, based on *Bcl2l11* and *Nr4a1* expression, suggested that CD25^+^ T~reg~P cells might be more apoptotic than Foxp3^lo^ T~reg~P cells ([Supplementary Fig. 3c](#SD2){ref-type="supplementary-material"}, [Supplementary Table 2](#SD4){ref-type="supplementary-material"}) we used annexin V staining to identify apoptotic cells in the thymus. Annexin V^+^ cells were detected in both T~reg~P cell subsets, although there were substantially more annexin V^+^ cells in the CD73^−^ CD25^+^ T~reg~P (12%) than in the CD73^−^ Foxp3^lo^ T~reg~P cells (3.3%; [Fig. 3d](#F3){ref-type="fig"}). We also stained thymocytes for cleaved caspase-3 (casp-3). CD25^+^ T~reg~P were enriched four-fold for casp-3^+^ cells compared to Foxp3^lo^ T~reg~P cells ([Fig. 3e](#F3){ref-type="fig"}). Thus, CD25^+^ T~reg~P cells interacted most strongly with self-antigen in the thymus and contained a higher fraction of apoptotic cells, suggesting they were undergoing negative selection.

We next examined where Foxp3^lo^ TregP were located in the thymus. Histocytometry ^[@R21]^ experiments in C57Bl/6 mice thymi indicated that mature CD25^+^Foxp3^+^ T~reg~ cells were largely restricted to the thymic medulla ([Fig.4a](#F4){ref-type="fig"},[b](#F4){ref-type="fig"}), consistent with agonist-driven T~reg~ selection occurring in the thymic medulla. In contrast, Foxp3^lo^ T~reg~P cells were found both in the thymic medulla and some (20%) in the thymic cortex ([Fig. 4 a](#F4){ref-type="fig"},[b](#F4){ref-type="fig"}), suggesting that at least some Foxp3^lo^ T~reg~P cells were selected on cortical antigens. Thus, CD25^+^ and Foxp3^lo^ T~reg~P subsets differentiate with distinct kinetics and exhibit different rates of apoptosis; moreover, a fraction of the Foxp3^lo^ T~reg~P subset share features with conventional (i.e., non-Treg) T cells undergoing positive selection, which also occurs in the thymic cortex.

NF-kB is critical for the development of Foxp3^lo^ T~reg~P cells {#S6}
----------------------------------------------------------------

We next assessed the effect of co-stimulation and downstream signaling pathways on the development of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P. *Cd28*^*−/−*^ thymi exhibited a 1.7-fold decrease in abundance of CD25^+^ T~reg~P, and a 6.7-fold decrease in abundance of Foxp3^lo^ T~reg~P compared to thymi from wild-type mice ([Fig. 5a](#F5){ref-type="fig"}). Similar results were found in CD28-AYAA mice, which express a mutant CD28 lacking the PYAP motif that links CD28 to activation of the transcription factor NF-κB (data not shown), but not in CD28-Y170F mice, which express a mutant CD28 lacking Y170, which links CD28 to signaling through PI3K (data not shown). Conversely, IKK-CA mice, which express a constitutively active from of IKK that leads to constitutive NF-κB activation, had a selective increase in Foxp3^lo^ T~reg~P cells (data not shown). A caveat of the analysis in CD28-AYAA, CD28-Y170F and IKK-CA mice is the lack of CD73 staining to exclude recirculating mature effector T cells and T~reg~ cells from the CD25^+^Foxp3^−^ T~reg~P and CD25^−^FOXP3^lo^ T~reg~P gates, respectively. Finally, we examined the effect of the downstream transcription factor NF-κB1 on T~reg~ cell development. *Nfkb1*^*−/−*^ mice had a 3.6 fold reduction in the abundance of CD73^−^Foxp3^lo^ T~reg~P cells compared to thymi from wild-type mice, while CD73^−^CD25^+^ T~reg~P cell abundance was unaffected ([Fig. 5b](#F5){ref-type="fig"}). These results suggest that co-stimulation, and especially activation of NF-κB1, were selectively required for the formation of Foxp3^lo^ T~reg~P.

CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P development is regulated by distinct enhancers {#S7}
------------------------------------------------------------------------------------

To examine whether Foxp3 was required for the development of T~reg~ cells from both CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P we used *Foxp3-GFP*^*KIN*^ mice, in which a GFP reporter construct is knocked-into the *Foxp3* locus and generates a GFP-Foxp3 fusion protein ^[@R22]^. These mice express normal amounts of GFP-Foxp3 protein, but have been described as functional Foxp3 hypomorphs ^[@R23],\ [@R24]^. Following gating on CD4^+^CD73^−^ thymocytes, we found that *Foxp3-GFP*^*KIN*^ mice had a significant reduction in the frequency Foxp3^lo^ T~reg~P compared to thymi from wild-type mice, while the abundance CD25^+^ T~reg~P was unaffected ([Fig. 5c](#F5){ref-type="fig"}). To examine this in more detail we analyzed *Foxp3-GFP*^KIN^ mice lacking the *Foxp3* regulatory element *Cns3* (called *Cns3*^*−/−*^ mice hereafter). *Cns3*^*−/−*^ mice, which are known to have a \~40% reduction in the frequency of T~reg~ cells in the thymus ^[@R25]^, have selective defects in immune tolerance and a T~reg~ cell bias towards higher self-reactivity ^[@R26]^. *Cns3*^*−/−*^ mice lacked Foxp3^lo^ T~reg~P cells ([Fig. 5c](#F5){ref-type="fig"}). Consistent with previous reports ^[@R25]^, mature CD25^+^Foxp3^+^ T~reg~ cells were also substantially reduced in *Cns3*^*−/−*^ mice compared to wild-type mice, and the defect was about twice as large (\~80% reduction) when gating on CD73^−^ cells to eliminate mature recirculating T~reg~ cells ([Fig. 5c](#F5){ref-type="fig"}). Importantly, mature CD25^+^Foxp3^+^ CD73^+^ T~reg~ cells in *Cns3*^*−/−*^ and wild-type mice expressed comparable amounts of Foxp3 ([Supplementary Fig. 6a](#SD2){ref-type="supplementary-material"}), indicating that *Cns3* was not required for Foxp3 expression. CD25^+^ T~reg~P cells isolated from wild-type, *Foxp3-GFP*^KIN^ or *Cns3*^*−/−*^ mice cultured in vitro upregulated Foxp3 and differentiated into mature CD25^+^Foxp3^+^ T~reg~ cells with comparable efficiency when stimulated with IL-2 ([Fig. 5d](#F5){ref-type="fig"}), suggesting *Cns3* was not required for the expression of *Foxp3* in mature T~reg~ cells. These results indicated that the development of T~reg~ cells from Foxp3^lo^ T~reg~P was blocked in the absence of *Cns3* and mature T~reg~ cells developed only from CD25^+^ T~reg~P cells in *Cns3*^*−/−*^ mice.

A non-coding SNP that contributes to an increased risk for autoimmunity in humans was previously described in the *Il2ra* locus ^[@R27],\ [@R28],\ [@R29]^, specifically in enhancer CaRE4, which is required for rapid induction of *Il2ra* following TCR activation ^[@R30]^. Next, we examined the role of this autoimmunity-associated *Il2ra* enhancer in T~reg~ cell development. Deletion of the CaRE4 *Il2ra* enhancer in the NOD mice background led to a significant reduction in the percentages of thymic CD25^+^ T~reg~P cells and mature T~reg~ cells compared to wild-type NOD mice ([Fig. 5e](#F5){ref-type="fig"}). In contrast, the percentage of Foxp3^lo^ T~reg~P cells was slightly increased, perhaps as a compensatory mechanism. This decrease in CD25^+^ T~reg~P cells was not due to a lack of CD25 expression in general, as the expression of CD25 on mature T~reg~ cells, or on the remaining CD25^+^ T~reg~P, was not reduced compared to wild-type controls ([Supplementary Fig. 6b](#SD2){ref-type="supplementary-material"} and data not shown). Collectively these data suggest that the development of T~reg~ cells from CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells was controlled by distinct regulatory circuits.

Inhibition of negative selection pathways expand CD25^+^ T~reg~P cells {#S8}
----------------------------------------------------------------------

To further probe if CD25^+^ T~reg~P cells were undergoing negative selection, we examined the development of T~reg~ cells in *Itk*^*−/−*^ mice, as mice lacking the tyrosine kinase ITK have defects in negative selection ^[@R31]^. *Itk*^*−/−*^ thymi had higher frequencies of mature thymic CD25^+^Foxp3^+^ T~reg~ cells ^[@R32]^, as well as CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells ([Fig. 6a](#F6){ref-type="fig"}). The adaptor protein ADAP, which is downstream of ITK, is also required for efficient negative selection^[@R33]^. Thymi from *Adap*^*−/−*^ mice showed an increase in the abundance CD25^+^ T~reg~P, but no change in Foxp3^lo^ T~reg~P cells compared to wild-type ([Fig. 6b](#F6){ref-type="fig"}). The frequency of mature CD25^+^Foxp3^+^ T~reg~ cells in the thymus was also significantly increased in *Adap*^*−/−*^ mice compared to wild-type ([Fig. 6b](#F6){ref-type="fig"}). Thus, *Adap*^*−/−*^ mice have a selective increase in CD25^+^ T~reg~P cells compared to wild-type mice. A potential explanation for the discrepancy between *Itk*^*−/−*^ and *Adap*^*−/−*^ mice is that ITK deficiency is known to induce increased production of IL-4 in iNKT cells in the thymus ^[@R34],\ [@R35]^, while ADAP deficiency does not. To examine if the different phenotypes in terms of T~reg~ cell development in *Adap*^*−/−*^ and *Itk*^*−/−*^ mice were linked to IL-4 production we examined T~reg~ cell development in *Itk*^*−/−*^ and *Itk*^*−/−*^ *x Il4ra*^*−/−*^ mice. Compared to *Itk*^*−/−*^ mice, the increase in abundance of Foxp3^lo^ T~reg~P cells was lost in the thymi of *Itk*^*−/−*^ *x Il4ra*^*−/−*^ mice ([Fig. 6a](#F6){ref-type="fig"},[c](#F6){ref-type="fig"}), suggesting that the increase in Foxp3^lo^ T~reg~P cells in *Itk*^*−/−*^ mice was due to the increased amounts of IL-4 present in the thymi of these mice. Thus CD25^+^ TregP cells are selectively pruned by the ITK-ADAP pathway required for negative selection.

CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells have distinct cytokine responsiveness {#S9}
---------------------------------------------------------------------------------

IL-2, and to a lesser degree IL-15, are the predominant cytokines that drive the STAT5-dependent differentiation of CD25^+^ T~reg~P cells into mature T~reg~ cells ^[@R1],\ [@R2],\ [@R4],\ [@R36],\ [@R37]^. Because the ability of Foxp3^lo^ T~reg~P cells to differentiate into mature T~reg~ cells in response to IL-4 has not been evaluated, we asked if IL-4 could affect the differentiation of CD25^+^ T~reg~P or Foxp3^lo^ T~reg~P cell subsets into mature T~reg~ cells. As reported previously ^[@R1],\ [@R37]^, IL-4 did not cause robust conversion of thymically derived CD25^+^ T~reg~P cells into mature T~reg~ cells, but supported substantial conversion of thymically-derived Foxp3^lo^ T~reg~P into mature CD25^+^Foxp3^+^ T~reg~ cells in an *in vitro* assay ([Fig. 7a](#F7){ref-type="fig"}). Foxp3^lo^ T~reg~P had slightly higher expression of the IL-4 receptor (IL-4Ra) compared to CD25^+^ T~reg~P ([Fig. 7b](#F7){ref-type="fig"}), which we considered unlikely to account for the difference in the differentiation of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells in response to IL-4. In addition, although IL-4 converted Foxp3^lo^ T~reg~P cells into mature T~reg~ cells, these cells expressed less CD25 and Foxp3 than those stimulated with IL-2 alone ([Supplementary Fig. 7a](#SD2){ref-type="supplementary-material"}--[d](#SD2){ref-type="supplementary-material"}).

What cells drive production of IL-4 in the thymus remains unclear. In humans, the Hassall's corpuscles, a distinct anatomical feature of the thymus containing cells that resemble Tuft cells, are important for T~reg~ cell development ^[@R38]^. Tuft cells were also reported in the murine thymi ^[@R39],\ [@R40]^ and are major producers of IL-25, which induces IL-4 production in other cell types ^[@R41]^. To test whether thymic tuft cells influenced T~reg~P cell differentiation, we examined T~reg~ cell development in *Pou2f3*^*−/−*^ mice, which lack the transcription factor POU2F3, which is required for the development of tuft cells. We observed an \~30% decrease in frequency of Foxp3^lo^ T~reg~P, but not CD25^+^ T~reg~P cell development in *Pou2f3*^*−/−*^ thymi compared to wild-type ([Fig. 7c](#F7){ref-type="fig"}). To determine if iNKT cells, the canonical producers of IL-4 in the thymus, selectively affected the development of Foxp3^lo^ T~reg~P cells we examined the frequency of T~reg~P in *Cd1d*^*−/−*^ mice, which lack NKT cells. There was an \~20% reduction in the abundance of Foxp3^lo^ T~reg~P cells in the *Cd1d*^*−/−*^ thymi compared to wild-type Balb/c controls ([Fig. 7d](#F7){ref-type="fig"}). This effect was only observed in Balb/c mice, which produce abundant NKT-derived IL-4, and not in C57Bl/6 mice, in which NKT cells make very little IL-4 (data not shown). Thus, CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells development have distinct dependence on thymic tuft cells, and this is likely partially mediated via tuft cell induction of IL-4 production in iNKT cells.

CD25^+^ and Foxp3^lo^ TRP exhibit distinct functions {#S10}
----------------------------------------------------

Next we tested whether the mature T~reg~ cells derived from CD25^+^ T~reg~P or Foxp3^lo^ T~reg~P cells had different abilities to prevent distinct types of autoimmune diseases, driven by different auto-antigens. To test whether mature T~reg~ cells generated from CD25^+^ T~reg~P cells differed in their ability to suppress autoimmunity in the central nervous system when compared to Foxp3^lo^ T~reg~P-generated T~reg~ cells, we isolated thymic CD25^+^ T~reg~P or Foxp3^lo^ T~reg~P cells, transferred them separately into individual C57Bl/6 host mice 1 day before immunization with MOG~35--55~ peptide and monitored the development of EAE symptoms. Transfer of mature T~reg~ cells is known to prevent or ameliorate symptoms in this EAE model ^[@R42]^. Mice receiving Foxp3^lo^ T~reg~P showed similar disease scores throughout the study as mice without T~reg~P transfer ([Fig. 8a](#F8){ref-type="fig"}). In contrast, disease progression and severity in mice that received CD25^+^ T~reg~P were significantly blunted from day 14 through 18 after disease induction compared to mice receiving no T~reg~P or Foxp3^lo^ T~reg~P cells ([Fig. 8a](#F8){ref-type="fig"},[b](#F8){ref-type="fig"}). The number of congenically-marked donor Foxp3^+^ T~reg~ cells observed following transfer of CD25^+^ or Foxp3^lo^ T~reg~P cells was similar in the spleen at the endpoint of the experiment, 20 days after T~reg~P transfer ([Fig. 8c](#F8){ref-type="fig"}), suggesting the conversion of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P into mature T~reg~ cells was similar. However, transferred Foxp3^lo^ T~reg~P cells prevented weight loss in a T cell transfer model of colitis ([Supplementary Fig. 8](#SD2){ref-type="supplementary-material"}), demonstrating the suppressor activity of the Foxp3^lo^ T~reg~P-derived T~reg~ cells was normal. Finally, we used MOG:I-A^b^ tetramers in combination with magnetic bead enrichment approaches to identify MOG:I-A^b^-specific T~reg~ cells and T~reg~P in the thymus of wild-type mice. We found MOG:I-A^b^-specific T cells in the CD25^+^ T~reg~P and mature T~reg~ cell subsets, but only observed one MOG:I-A^b^-specific T cell in the Foxp3^lo^ T~reg~P in 15 mice examined ([Fig. 8d](#F8){ref-type="fig"},[e](#F8){ref-type="fig"}), suggesting MOG:I-A^b^-specific T~reg~ cells were almost always generated from the CD25^+^ T~reg~P and were specifically required for protection against EAE.

Discussion {#S11}
==========

Here we found that both CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P contributed to mature T~reg~ development in the thymus, and that in our hands they did so relatively equivalently. However, these two distinct TregP cell subsets differed in many important ways. They utilized different signaling pathways and enhancers for their differentiation, were affected in distinct ways by different stromal cells and cytokines and expressed distinct TCR repertoires and RNA transcriptomes. Most importantly, T~reg~ cells derived from CD25^+^T~reg~P versus Foxp3^lo^ T~reg~P subsets had distinct roles in protecting against autoimmunity. Thus, there are at least two different developmental pathways in the thymus that contribute substantially to the generation of the mature T~reg~ cell repertoire.

Several pieces of evidence support the notion that mature T~reg~ cells derived from both CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P cells are required for full maintenance of immune tolerance. Both the *Foxp3-GFP*^*KIN*^ hypomorph and *Cns3*^*−/−*^ mice had defects in generating Foxp3^lo^ T~reg~P and specific defects in immune tolerance. The *Foxp3-GFP*^*KIN*^ mice have a relatively mild defect in immune tolerance that is only revealed on distinct genetic backgrounds^[@R23],\ [@R24]^. In contrast, *Cns3*^*−/−*^ mice have unique defects in immune tolerance, such as greater inflammation in the lung than wild-type mice^[@R26]^. In addition, *Cns3*^*−/−*^ mice have increased titers of specific autoantibodies ^[@R26]^. Because *Cns3*^*−/−*^ mice selectively lacked Foxp3^lo^ but not CD25^+^ T~reg~P, this suggests a unique role for Foxp3^lo^ T~reg~P-derived mature T~reg~ cells in preventing autoimmunity.

Additional studies suggest a unique role for CD25^+^ T~reg~P in promoting immune tolerance. The *CaRE4* enhancer in the *Il2ra* locus harbors an autoimmunity risk variant that promotes susceptibility to inflammatory bowel disease, but protection against diabetes ^[@R27],\ [@R28],\ [@R29]^. Deletion of this enhancer resulted in a selective decrease in CD25^+^ T~reg~P, suggesting that CD25^+^ T~reg~P-derived T~reg~ cells could have an important role in protecting against inflammatory bowel disease. Likewise, *Cns3*^*−/−*^ mice exhibit increased protection against EAE ^[@R26]^. Because T~reg~ cells in *Cns3*^*−/−*^ mice are almost exclusively derived from CD25^+^ T~reg~P, this suggests CD25^+^ T~reg~P -derived T~reg~ cells protect against EAE. We directly confirmed this idea by showing that CD25^+^ T~reg~P-derived T~reg~ cells provided robust protection from EAE while Foxp3^lo^ T~reg~P-derived T~reg~ cells did not. Thus, modulating the frequency of CD25^+^ T~reg~P results in differential protection against autoimmunity. This observation has important translational implications, as it indicates that T~reg~ cells with select TCRs can be identified that have uniquely potent efficacy versus specific types of autoimmune disease.

The presence of more than one developmental pathway leading to mature T~reg~ cells raises the question of why such a system has evolved. T~reg~ cells are required to prevent responses to self-antigens and commensal antigens, as well as dampen anti-pathogen immune responses once these agents have been cleared. Establishing such a diverse repertoire requires the generation of T~reg~ cells able to recognize high-affinity self-antigens. Such a population could be generated via a process of agonist selection in the thymus. However, agonist selection is unlikely to generate the broad repertoire of T~reg~ cells needed to prevent immune responses to commensal organisms or to limit responses to foreign pathogens. In many ways this resembles the problem faced by conventional thymocytes, which must generate a repertoire able to recognize a vast array of antigens that they never see in the thymus. Thus, establishing a broader non-self-focused repertoire for T~reg~ cells may require a process that resembles positive selection for conventional thymocytes. We show that T~reg~ cells developed through two distinct developmental programs that exhibit such characteristics. CD25^+^ T~reg~P developed through a process of agonist selection that shared many similarities with the underlying process of negative selection and would result in mature T~reg~ cells focused on TCRs with high-affinity for thymic self-antigens. Foxp3^lo^ T~reg~P developed through a mechanism that could be akin to positive selection of T~reg~ cells, resulting in a broader repertoire able to react with both self- and non-self antigens. As such, thymic T~reg~ cells derived from Foxp3^lo^ T~reg~P could complement the function of induced peripheral T~reg~ cells. Our model also suggests that the *Cns3* regulatory element evolved to promote the development of mature T~reg~ cells through the Foxp3^lo^ T~reg~P pathway. Finally, the genetic variability that altered the relative balance of these two developmental pathways also altered the T~reg~ cell repertoire and correlated with susceptibility to distinct forms of autoimmunity. Given the differences in signaling pathways and cytokines that controlled these two developmental pathways, specific targeting of each T~reg~ cell population might help patients with various autoimmune defects.

Online Methods {#S12}
==============

Mice. {#S13}
-----

Mice were housed in specific pathogen--free facilities at the University of Minnesota, Cornell University, Salk Institute or University of California San Francisco, and experiments were in accordance with protocols approved by the Institutional Animal Care and Use Committees of these respective institutions. Exceptions are germ-free mice housed in germ-free facilities at the University of Chicago and mice with a normalized microbial experience which were housed in the University of Minnesota's mouse vivarium. Pet store mice were purchased from various pet stores in the greater Minneapolis-St. Paul metropolitan area. Information about the age of the pet store mice was not available from the vendor. Co-housing of SPF mice with sex-matched pet store partner was performed as described^[@R12]^ within the University of Minnesota BSL-3 facility. Conversion efficiency was confirmed by assessing the conversion of naïve CD8^+^ T cells into CD8^+^ memory T cells; effective conversion correlated with \~30--60% CD8^+^CD44^hi^ T cells. All relevant ethical guidelines have been followed. *Foxp3-GFP* mice (006772), *Foxp3-RFP* mice (008374) were from the Jackson Laboratory. CD45.1^+^ (B6.SJL) mice were from the US National Cancer Institute. *Nur77-GFP* BAC reporter mice, *Rag2-GFP* reporter mice, *Cns3*^*−/−*^ and *Foxp3-GFP*^*KI*^, *CD28*^*−/−*^, *Nfkb1*^*−/−*^, *Itk*^*−/−*^, *Itk*^*−/−*^ *x Il4Ra*^*−/−*^, *Adap*^*−/−*^, *Il2ra EDEL*, *Itgal*^*−/−*^, *Rag2*^*−/−*^, *Cd1d*^*−/−*^ and *Tcliβ x TCRα*^*+/−*^ have been described previously ^[@R7],\ [@R14],\ [@R17],\ [@R22],\ [@R25],\ [@R30],\ [@R35],\ [@R43],\ [@R44],\ [@R45],\ [@R46],\ [@R47],\ [@R48]^. Mice were generally six to eight weeks old but ranged from four to sixteen weeks old. Mice were randomly selected for experiments, in age-matched cohorts. The investigators were not 'blinded' to genotype during data acquisition.

Tissue preparation and cell isolation. {#S14}
--------------------------------------

For analysis of thymocyte and Treg development thymi were mechanically dissociated into 1x PBS with 2% FBS and 2 mM EDTA, pH 7.4, using frosted glass slides. Cells suspensions were passed through 70 µm filters and washed prior to staining.

Flow cytometry and antibodies. {#S15}
------------------------------

All flow cytometry analysis was conducted in the University of Minnesota Flow Cytometry Core Facility using BD LSR II and Fortessa cytometers (BD, San Jose, CA). For surface staining, cells were stained for 20 minutes with fluorochrome-conjugated antibodies prior to washing and analysis or intracellular staining. Intracellular detection of Foxp3, Cleaved Caspase-3 and GFP was performed as previously described ^[@R2]^ using the eBioscience Transcription Factor staining kit. When staining for GFP, *Rag2-GFP* thymi were fixed for 10 minutes at room temperature in 1.6% PFA prior to intracellular staining of GFP and Foxp3 using the eBioscience Transcription Factor staining kit. For apoptosis assays, thymi were harvested and mechanically dissociated into 1x PBS on ice. Following surface staining cells were washed into Annexin V binding buffer (eBioscience San Diego, CA) and stained with Annexin V. Specific antibodies used are listed below. For tetramer staining, single cell thymocyte suspensions were treated with Dasatinib (Axon Medchem) at 50nM in complete RPMI for 20 minutes at 37°C followed by dual (APC and PE conjugated) MOG~38--48~ tetramer ^[@R49]^ staining at 10nM for an additional 45 minutes in complete RPMI (10% FBS, 1% glutamine, 1% penicillin-streptomycin, 1% NEAA, 10mM HEPES, 50uM BME) at 37°C. Tetramer stained cells were washed and incubated with anti-APC and anti-PE microbeads (Miltenyi Biotec) for 30 minutes on ice. Cells were washed and run over a LS column and unbound and bound fractions were collected, stained and analyzed as described above. A complete list of staining reagents is available as a supplemental reagent table.

Ultrasound guided intrathymic injection {#S16}
---------------------------------------

Injections were performed largely as described previously ^[@R50]^. Briefly, mice were anesthetized with 2--4% isofluorane in medical gas (21% oxygen, 79% nitrogen) in an acrylic chamber then transferred to the warmed ultrasound platform face up with the snout fastened in a facemask delivering 2--4% isofluorane and medical gas. Depilatory cream was used to remove hair from the mid-upper ventral thoracic region prior to applying ultrasound gel. Using the Vevo 2100 ultrasound, the MS550D probe was lowered parallel to the left or right side of the sternum. The ultrasound image generated was used to guide an insulin syringe (27G) into the thymus and visualize the injection of the 10--20uL cell suspension.

Immunofluorescence and histo-cytometry {#S17}
--------------------------------------

Immunofluorescence analysis of thymi was described previously ^[@R51]^. Thymi were washed, fixed with 4% paraformaldehyde (PFA) for 1 h and snap frozen. 5-μm sections were blocked with PBS containing 5% bovine serum albumin (BSA) and goat serum (Jackson Laboratory) before staining. The sections were then covered with Prolong anti-fade mounting medium (Life Technologies) and images were obtained 1 to 3 d later with a Leica DM6000B Epi-Fluorescent microscope.

Histo-cytometry analysis was performed as described previously ^[@R21]^.

TCR sequencing {#S18}
--------------

CD4SP thymocytes were enriched by magnetic depletion using biotinylated anti-CD8/Ter119 antibodies followed by secondary labelling with streptavidin--conjugated microbeads (Miltenyi Biotec). Enriched cells are labelled with fluorchrome-conjugated anti-CD4, CD25 and streptavidin, while Foxp3 is marked with the RFP reporter, prior to sorting on the BD Aria sorter (BD Biosciences). TCR sequencing was performed as described previously ^[@R52]^. Briefly, CD4^+^CD25^−^Foxp3^−^, CD4^+^CD25^+^Foxp3^−^, CD4^+^CD25^−^Foxp3^lo^ and CD4^+^CD25^+^Foxp3^+^ populations are sorted into lysis buffer (Buffer RLT+BME). cDNA was generated from these samples using the RNeasy kit (QIAGEN Valencia, CA). CDR3 Vα2 TCRs were sequenced using an Ion Torrent as previously described. TCRs representing \>20% of the reads in the T~reg~ compartment, which influence distributions disproportionally, were excluded from analysis as described ^[@R53]^.

T~reg~ progenitor conversion assays. {#S19}
------------------------------------

T~reg~ progenitors were isolated as previously described ^[@R2]^. Briefly, *Foxp3-GFP* thymi were dissected, dissociated, and pooled CD4SP cells were enriched by magnetically depleting with biotinylated anti-CD8 and Ter119 antibodies (eBioscience) followed by secondary labeling with streptavidin-conjugated microbeads (Miltenyi Biotec). Enriched CD4SP cells were stained with fluorchrome-conjugated anti-CD4, CD25, CD73 and streptavidin prior to sorting CD4^+^CD73^−^CD25^+^GFP^−^, CD4^+^CD73^−^CD25^−^GFP^+^, or CD4^+^CD73^−^CD25^+^GFP^+^ cells using a BD Facs Aria sorter (BD Biosciences). Purified T~reg~ cell progenitors or T~reg~ cells were incubated in complete RPMI and supplemented with human IL2 from R&D Systems (Minneapolis, MN) or mouse IL4 from Tonbo Biosciences (San Diego, CA). After 72 hours, cells were harvested, stained with anti-CD4, CD8 and CD25 antibodies and analyzed by flow cytometry for the percentage or number of cells that express CD25 and GFP after incubation.

Mapping and analysis of single cell sequencing {#S20}
----------------------------------------------

CD4^+^CD73^−^CD25^+^Foxp3^−^, CD4^+^CD73^−^CD25^−^Foxp3^lo^ and CD4^+^CD73^−^CD25^+^Foxp3^+^ cells were isolated from a single *Foxp3-GFP* thymus using a BD Facs Aria sorter. Cells were resuspended at 10^6^ cells/mL in 50%FBS in 1xPBS before being counted and captured using the 10X Genomics (San Francisco, CA) Single Cell 3' Solution.

A custom genome was created by adding the sequence for the FoxP3-GFP construct ^[@R54]^ as a new chromosome to the Ensembl GRCm38 reference and gtf file (version 89). The gene annotation file (gtf) was then filtered further to contain only protein coding genes. The 10x Genomic Cellranger pipeline (version 2.2.0 <https://support.10xgenomics.com/single-cell-gene-expression/software/overview/welcome>) was used to align reads and generate counts for each sorted population (or library). Sorted populations were then combined using the depth normalization mode.

The Seurat R Package (version 1.4.0.12) was used to analyze the mapped single cell reads. The data was filtered to include cells that contained 100--2500 unique gene counts and expressed more than 5 genes. Global-scaling normalization was applied to the filtered data as described in the default settings in the Seurat package. The data was then scaled to regress out sequencing depth. Linear dimensional reduction (PCA) was performed on the most variable genes (2010 genes). Heatmap analysis of different PCs and an elbow plot were created to decide on proceeding with 9 PCs for cluster analysis using the Seurat function 'FindCluster'. To visualize the clusters, non-linear dimensional reduction (tSNE) was performed using the 9 PCs. Clusters were assigned to a specific population by comparing cells labeled for the original sorted population and cellular markers. The R packages plot3D (version 1.1.1) and threejs (version 0.3.1) were used to create 3D visualization of the tSNE data. Differential expression ("bimod" McDavid et al., 2013) was calculated for each cluster against all other clusters to identify potential markers for each individual cluster. Differential expression was also calculated between individual clusters using the same method.

Experimental Autoimmune Encephalomyelitis Induction {#S21}
---------------------------------------------------

EAE was induced in mice as described previously ^[@R55]^. Briefly, on Day −1 sorted T~reg~P populations (4×10^5^-5×10^5^) were transferred i.v. into CD45.1 congenic mice. On Day 0 mice were immunized with 200ug of MOG~35--55~ emulsified in CFA with 4mg/mL heat killed Tb. Immunization was performed with 2, 50uL s.c. injections of emulsion on left/right flank of the lower back. Mice were treated with 200ng Pertussis Toxin on day 0 and day 2 via i.p. injection in 1xPBS. Mice were monitored for disease progression and treated with s.c. normal saline or given wet food on the cage floor, as described previously ^[@R55]^.

Transfer colitis induction {#S22}
--------------------------

Colitis was induced as previously described ^[@R56]^. Briefly, 5×10^5^ CD4^+^CD45RB^hi^ cells were transferred via i.v. or i.p. injection into *Rag*^*−/−*^ recipient mice. Sorted T~reg~P were transferred via i.p. injection in a split dose (2.5×10^5^ on days 1 and 7) or a single dose (5×10^5^ on day 21). Mice were weighed weekly to monitor disease progress.

Statistical analysis {#S23}
--------------------

Statistical tests used to analyze data are included within the figure legends. Briefly, comparisons of 2 groups were done by either, paired *t*-test (paired, normal data), Wilcoxon matched-pairs test (paired, non-normal data), *t*-test (non-paired, normal data) or Mann-Whitney (non-paired, non-normal data); tests were always two-sided. Comparisons of 3 or more groups was done by one-way ANOVA (non-paired, normal data), Kruskal-Wallis (non-paired, non-normal data), or Friedman test (paired, non-normal data). P-values \<0.05 were considered significant. Statistics were calculated using Prism (GraphPad Software, LaJolla, CA). All data, except those specifically mentioned in figure legends, are displayed as mean ± standard deviation.

Supplementary Material {#SM1}
======================

We thank G. Hubbard, A. Rost, A. Meskic, D. Duerre and H. Wiesolek for technical assistance, T. Martin, N. Shah, J. Motl and P. Champoux for cell sorting and maintenance of the Flow Cytometry Core Facility at the University of Minnesota (5P01AI035296), S. Hamilton, M. Pierson and funding from the University of Minnesota academic health center for maintaining the NME mouse facility, P. Fink for providing initial *Rag2-GFP* thymi, B. Burbach and Y. Shimizu for *Adap*^*−/−*^ mice, M. Jenkins and T. Dileepan for MOG:I-Ab tetramer, and C. Katerndahl and L. Heltemes-Harris for helpful commentary and for reviewing the manuscript. D.L.O. and S.A.M. were supported by an immunology training grant (2T32AI007313). S.A.M. was also supported by an individual predoctoral F30 fellowship from the NIH (F30DK096844). J.A.S. was supported by University of Minnesota Medical Foundation grant UMF0020624 and NIH grants 5U24AI118635 and R01AI106791. Y.Z. was supported by NIH grant R01AI107027, U.B. and C.B.W. were supported by grants from the Children's Hospital of Wisconsin, C.B.W. was also supported by NIH grant R01AI085090--07A1, A.M. and M.S.A were supported by NIH grant DP3DK111914--01 and A.M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is an investigator at the Chan Zuckerberg Biohub, M.A. was supported by NIH grant R01AI115716, M.S.A. was supported by NIH grant R37 AI097457, A.A. was supported by NIH grants AI108958, AI120701, AI126814, and AI129422 to A.A. and W.H., W.H. was supported by NIH grant AI29422 (to WH and AA) a Careers in Immunology Fellowship from the American Association of Immunologists, a Faculty Development Award, and a competitive research grant from Louisiana State University, and a pilot award from the LSU-Tulane Center for Experimental Infectious Diseases Research funded by NIH grant GM110760. M.A.F. was supported by NIH grants AI124512, AI113138, AI061165, CA154998, CA151845, and CA185062.

A.M. is a co-founder of Spotlight Therapeutics. A.M. has served as an advisor to Juno Therapeutics and is a member of the scientific advisory board at PACT Pharma. The Marson laboratory has received sponsored research support from Juno Therapeutics, Epinomics and Sanofi, and a gift from Gilead. AA has received sponsored research support from 3M. MAF has received sponsored research support from Merck.

Data availability statement

The data that support the findings of this study are available from the corresponding author upon request. Single-Cell RNA-Seq data is deposited at GEO with the following accession codes: GSE123067

Code availability statement

Source code for bio-informatic analyses is attached as a supplementary file.

Competing financial interests

Other authors declare no competing financial interests.

![Two thymic T~reg~ progenitor cell populations exist. a) Gating scheme used to quantify or isolate CD25^+^Foxp3^−^ and CD25^−^Foxp3^lo^ T~reg~P cell populations throughout the manuscript. b) Quantification of the proportion of sorted congenically distinct (CD90.2^+^CD45.2^+^ or CD90.1^+^CD45.2^+^) CD25^+^ and Foxp3^lo^ T~reg~P cells co-injected into the thymi of CD45.1^+^ mice that differentiated into CD25^+^Foxp3^+^ T~reg~ cells 6 post-injection. Each dot represents a single recipient mouse; pairing represents data within the same recipient thymi. Data represents 3 independent experiments, n=9 mice. Data was analyzed by a two-sided paired *t* test. \* P\<0.05.](nihms-1514192-f0001){#F1}

![CD25^+^ and Foxp3^lo^ T~reg~P are distinct thymic T~reg~ cell lineages. a) Morisita-Horn indices comparing similarity of Vα2 CDR3 repertoires generated by TCR sequencing of CD4^+^CD25^−^Foxp3^−^, CD4^+^CD25^+^Foxp3^−^ T~reg~P, CD4^+^CD25^−^Foxp3^lo^ T~reg~P and CD4^+^CD25^+^Foxp3^lo^ mature T~reg~ cells isolated from Tcliβ^+^*TCRa*^*+/−*^ mice. b) Plot of the ratio of Morisita-Horn similarity indices comparing TCRs in CD25^+^ and Foxp3^lo^ T~reg~P cell populations, and TCRs in CD25^+^T~reg~P and mature T~reg~ cells or Foxp3^lo^ T~reg~P and mature T~reg~ cells. CD25^+^ T~reg~P cell comparisons are shown in green and Foxp3^lo^ T~reg~P cell comparisons are shown in orange. Data represents 2 independent experiments, n=4 mice. Data was analyzed by a two-sided paired *t* test. c,d) Flow cytomyerty analysis of Nur77-GFP MFI in CD25^+^Foxp3^−^ T~reg~P, CD25^−^Foxp3^lo^ TregP and CD25^+^Foxp3^+^ mature T~reg~ cells obtained from thymi of Nur77-GFP reporter mice. Dots represent individual mice. Data are displayed as mean ± SD and represents 7 independent experiments, n=19 mice. Data was analyzed via a two-sided paired Friedman test with Dunn's multiple comparisons test. e) Left- Three-dimensional tSNE plots from 10X Genomics single-cell RNA-Seq data set for sorted CD25^+^ T~reg~P, Foxp3~lo~ T~reg~P and CD25^+^Foxp3^+^ T~reg~ cells displaying relationships between individual cells with color-coding based on flow cytometry sort origin. Right- Three-dimensional tSNE plots of identical data to left panel but color-coded based on gene expression profiles. f) Heatmap for the top 10 differentially regulated genes from each cluster derived from subfigure e. Each column represents gene expression for an individual cell; yellow is up and purple is down. Data from e,f is representative of 3 independent experiments, n=3 mice. \*P\<0.05, \*\*P\<0.0005, \*\*\*P\<0.0001.](nihms-1514192-f0002){#F2}

![CD25^+^ and Foxp3^lo^ T~reg~P cells are in discrete selection stages. a) Representative histograms of RAG2-GFP expression in CD4SP thymocytes obtained from thymi of RAG2-GFP mice. Bins are displayed from high (Bin 1) to low (Bin 8) RAG-GFP expression and cells in each bin are plotted for CD25 vs Foxp3 expression. Data shown are concatenated results from 3 mice and are representative of 7 independent experiments, n=9 mice. b) Representative flow cytometry plots of CD73 staining in CD4SP thymocytes and RAG2-GFP expression in CD73^−^ and CD73^+^ compartments. Data is representative of 5 experiments, n=5 mice. c) Representative flow cytometry plots (top) and quantification of the percent of CD4^+^CD73^−^ thymocytes differentiating into each T~reg~P cell population in WT versus *Itgal*^*−/−*^ thymi. Data represents 3 independent experiments, n= 16 WT and *Itgal*^*+/−*^ mice, n=12 *Itgal*^*−/−*^ mice. Data was analyzed by two-sided Mann-Whitney test. d) Left panels, Representative example of Annexin V expression on CD4^+^CD73^−^CD25^+^Foxp3^−^ T~reg~P (top green histogram) and CD4^+^CD73^−^CD25^−^Foxp3^lo^ T~reg~P (bottom orange histogram) thymocytes from *Foxp3-GFP* mice. Right panel, quantification of Annexin V staining on CD25^+^ T~reg~P and Foxp3~lo~ T~reg~P. Data represents 3 independent experiments, n=9 mice. Data were analyzed by two-sided Wilcoxon matched-pairs signed rank test. e) Left and middle panels, represenative examples of staining for CD25 and Foxp3 on CD4^+^CD73^−^ gated thymocytes from wild-type mice either negative (left panel) or positive (middle panel) for cleaved caspase-3. Right panel, quantification of the ratio of cleaved caspase-3-positive to cleaved caspase-3 negative CD25^+^ T~reg~P (green circles) or Foxp3lo T~reg~P; data represents 4 independent experiments, n=10 mice. Data were analyzed by two-sided Wilcoxon matched-pairs signed rank test. All data are displayed as mean ± SD. \*P\<0.05, \*\*P\<0.005, ns-not significant.](nihms-1514192-f0003){#F3}

![T~reg~ cells and Foxp3^lo^ T~reg~P cells show different localization in the thymus. a) Top left panels, representative histocytometry dot plots of thymocytes stained with antibodies to CD25, Foxp3 and TCRβ used to denote Foxp3^lo^ T~reg~P cells (CD25^−^Foxp3^+^TCRβ^+^) and T~reg~ cells (CD25^+^Foxp3^+^TCRβ^+^) within stained thymic sections. Bottom left panels, representative images of Foxp3^lo^ T~reg~P cells and T~reg~ cells. Right panels, thymic sections stained with antibodies to TCRb and RORgt used to delineate the thymic medulla (M) and cortex (C). Distribution of CD25^+^Foxp3^+^TCRβ^+^ T~reg~ cells (blue) and CD25^−^Foxp3^+^TCRβ^+^ Foxp3^lo^ T~reg~P cells (orange) within the thymic medulla and cortex (right). Scale bar represents 200μm. b) Distribution of Foxp3^lo^ T~reg~P cells and T~reg~ cells between thymic cortex and medulla, p value determined by Fisher's exact test. Data represents 1 experiment, n=2 mice. \*\*\*P\<0.0001.](nihms-1514192-f0004){#F4}

![Foxp3^lo^ T~reg~P cells are dependent on NFκB1 activation and the Foxp3 regulatory element *Cns3*. a), Left panels, shown are representative flow cytometry plots for CD4^+^CD8^−^CD73^−^ gated thymocytes antibodies from wild-type and *Cd28*^*−/−*^ mice stained with antibodies to CD25 and Foxp3 (1 experiment, n=4 wild-type and 5 *Cd28*^*−/−*^ mice). Right panels show cumulative data for all mice and depict the relative percentage of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P in CD4^+^CD8^−^CD73^−^ thymocytes from wild-type and *Cd28*^*−/−*^ mice. b), Shown are representative flow cytometry plots for CD4^+^CD8^−^CD73^−^ gated thymocytes from wild-type and *Nfkb1*^*−/−*^ mice stained with antibodies to CD25 and Foxp3 (3 independent experiments, n=19 wild-type and 11 *Nfkb1*^*−/−*^ mice). Right panels show cumulative data for all mice and depict the relative percentage of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P in CD4^+^CD8^−^CD73^−^ thymocytes from wild-type and *Nfkb1*^*−/−*^ mice c) Top panels, shown are representative flow cytometry plots for CD4^+^CD8^−^CD73^−^ gated thymocytes from wild-type, FOXP3-GFP^KIN^, and *Cns3*^*−/−*^ mice stained with antibodies to CD25 and Foxp3 (4 independent experiments, n=8 wild-type, 14 Foxp3-GFP^KIN^, and 14 *Cns3*^*−/−*^ mice). Right panels show quantification of cumulative data for all mice and depict relative percentage of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P in CD4^+^CD8^−^CD73^−^ thymocytes from wild-type (black circles), Foxp3-GFP^KIN^ (black squares), and *Cns3*^*−/−*^ (black triangles) mice. d) Shown are the percentages of CD25^+^Foxp3^+^ mature T~reg~ cells generated after stimulating sorted CD4^+^CD8^−^CD73^−^CD25^+^ T~reg~P cells from thymi of Foxp3-GFP^KIN^ and *Cns3*^*−/−*^ mice for 3 days with 0 U/ml IL2 (black circles, n=5 Foxp3-GFP^KIN^ and 5 *Cns3*^*−/−*^ mice), 0.2 U/ml IL2 (black squares, n=4 Foxp3-GFP^KIN^ and 5 *Cns3*^*−/−*^ mice), 1 U/ml IL2 (black triangles, n=5 Foxp3-GFP^KIN^ and 6 *Cns3*^*−/−*^ mice) and 100 U/ml (open circles, n= Foxp3-GFP^KIN^ and 5 *Cns3^−/−^* mice) and come from 2 independent experiments. e) Quantification of cumulative data from 2 independent experiments showing the relative percentage of CD25^+^ T~reg~P, Foxp3^lo^ T~reg~P and mature CD25^+^Foxp3^+^ T~reg~ cells from CD4^+^CD8^−^CD73^−^ gated thymocytes from wild-type (black circles) or EDEL mice, which lack the CaRE4 enhancer (black squares). Data represents 2 independent experiments, n=10 wild-type and 10 EDEL mice. a,b) Data was analyzed by two-sided unpaired *t* test. c) CD25^+^ T~reg~P cells (%) and Foxp3^lo^ T~reg~P cells (%) were analyzed by one-way ANOVA with Tukey's multiple comparison test and T~reg~ cells (%) was analyzed by Kruskal-Wallis test with Dunn's multiple comparison test. d) Data was analyzed by Kruskal-Wallis test with Dunn's multiple comparisons test. e) Data was analyzed by two-way ANOVA with Sidak multiple comparisons test. All data are displayed as mean ± standard deviation. \*\*P\<0.005, \*\*\*P\<0.0001, ns- not significant.](nihms-1514192-f0005){#F5}

![*Itk*^*−/−*^ mice have increased T~reg~ cell production from both T~reg~P cell pathways via distinct molecular mechanisms. a) Left panels, representative flow cytometry plots of CD4^+^CD8^−^CD73^−^ gated thymocytes from wild-type versus *Itk*^*−/−*^ mice stained with antibodies to CD25 and FOXP3. Right panels show cumulative data for all mice and depict the relative percentage of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P in CD4^+^CD8^−^CD73^−^ thymocytes from wild-type, *Itk*^*−/−*^, and *Itk*^*−/−*^ *x Il4ra*^*−/−*^mice (3 independent experiments, n=15 wild-type, 17 *Itk*^*−/−*^ mice, and 11 *Itk*^*−/−*^ *x Il4ra*^*−/−*^). b) Left panels, representative flow cytometry plots of CD4^+^CD8^−^CD73^−^ gated thymocytes from wild-type versus *Adap*^*−/−*^ mice stained with antibodies to CD25 and FOXP3. Right panels show cumulative data for all mice and depict the relative percentage of CD25^+^ T~reg~P and Foxp3^lo^ T~reg~P in CD4^+^CD8^−^CD73^−^ thymocytes from wild-type, and *Adap*^*−/−*^mice (3 independent experiments, n=12 wild-type and 12 *Adap*^*−/−*^ mice). c) .representative flow cytometry plots of CD4^+^CD8^−^CD73^−^ gated thymocytes from wild-type, *Itk*^*−/−*^ and *Itk*^*−/−*^ *x Il4ra*^*−/−*^mice stained with antibodies to CD25 and FOXP3. a) CD25^+^ T~reg~P cell (%) was analyzed by one-way ANOVA with Tukey's multiple comparisons test; Foxp3^lo^ T~reg~P cells (%) was analyzed by Kruskal-Wallis with Dunn's multiple comparisons test. b) Data was analyzed by two-sided Mann-Whitney test. All data are displayed as mean ± SD. \*P\<0.05, \*\*\*P\<0.0001, ns-not significant.](nihms-1514192-f0006){#F6}

![CD25^+^ and Foxp3^lo^ T~reg~P cells have distinct cytokine responsiveness. a) Percent of T~reg~ cells generated from sorted CD4^+^CD8^−^CD73^−^CD25^+^FOXP3^−^ and CD4^+^CD8^−^CD73^−^CD25^+^FOXP3^−^ T~reg~P cell subsets stimulated for 3 days with no cytokine (black circles, n=9 CD25^+^ T~reg~P and 7 Foxp3^lo^ T~reg~P cultures), 0.5 ng/ml IL4 (black squares, n= 3 CD25^+^ T~reg~P and 2 Foxp3^lo^ T~reg~P cultures), 1 ng/ml IL4 (black triangles, n= 9 CD25^+^ T~reg~P and 7 Foxp3^lo^ T~reg~P cultures), and 100 ng/ml IL4 (open circles, n= 9 CD25^+^ T~reg~P and 7 Foxp3^lo^ T~reg~P cultures) . Data is representative of 3 independent experiments (excluding 0.5 ng/mL IL4 stimulation which is from 1 experiment) and was analyzed by Kruskal-Wallis test with Dunn's multiple comparisons test. b) IL4Ra gMFI in CD25^+^ (black circles) and Foxp3^lo^ (black squares) T~reg~P cells from thymi of wild-type mice. Data is representative of 2 independent experiments, n=10 mice. Data analyzed by two-sided Wilcoxon matched-pairs signed rank test. c) Percent of CD4^+^CD8^−^CD73^−^CD25^+^Foxp3^−^ T~reg~P, CD4^+^CD8^−^CD73^−^CD25^−^Foxp3^lo^ T~reg~P, and CD4^+^CD8^−^CD73^−^CD25^+^Foxp3^+^ T~reg~ cells in thymi from wild-type (black circles, n=11 mice) and *Pou2f3*^*−/−*^ mice (black squares, n= 11 mice). Data is representative of 2 independent experiments, and was analyzed by a two-sided unpaired *t* test. d) Left panels, representative flow cytometry plots of CD4^+^CD8^−^CD73^−^ gated thymocytes from wildtype BALB/c and *Cd1d*^*−/−*^ BALB/c mice stained with antibodies to CD25 and Foxp3. Right panels, percent of CD4^+^CD8^−^CD73^−^CD25^+^Foxp3^−^ T~reg~P (left) and CD4^+^CD8^−^CD73^−^CD25^−^Foxp3^lo^ T~reg~P (right) in wild-type Balb/c (back circles) and Cd1d−/− Balb/c (black squares) mice. Data is representative of 2 independent experiments, n=6 mice-WT and 11 mice-*Cd1d*^*−/−*^ and was analyzed by two-sided unpaired t-test. All data are displayed as mean ± SD. \*P\<0.05, \*\*P\<0.005, \*\*\*P\<0.0001, ns-not significant.](nihms-1514192-f0007){#F7}

![CD25^+^ and Foxp3^lo^ T~reg~P cells are functionally distinct. a) Clinical score over 20-day time course of MOG~35--55~ peptide-induced experimental autoimmune encephalomyelitis in wild-type mice treated with no T~reg~ cells (red line and circles), Foxp3^lo^ T~reg~P (orange line and circles) and CD25+ T~reg~P (green lines and circles). Data was analyzed by two-sided unpaired t-tests with Holm-Sidak multiple comparisons correction. Asterisks mark values with adjusted p-values less than 0.05. Bars represent mean ± SEM. b) Cumulative EAE scores for control mice (no treatment, red circles), or mice injected with CD25+ T~reg~P (green squares) or Foxp3^lo^ T~reg~P (yellow triangles). Data was analyzed by Kruskal-Wallis test with Dunn's multiple comparisons test. Bar represents median. c) Number of donor T~reg~ cells recovered from the spleen of EAE-induced mice receiving CD25^+^ T~reg~P (black squares) and Foxp3^lo^ T~reg~P (black triangles). Data was analyzed by a two-sided unpaired *t* test. Bars represent mean ± SD. a-c) Data represent 2 independent experiments, n=6 mice per group. d) Representative gating strategy for thymic tetramer pulldowns. Dual tetramer gates are drawn on CD8^+^ thymocytes such that \~0% of CD8^+^ thymocytes appear in the double tetramer positive gate. This gate is applied to CD4^+^CD73^−^ thymocytes to identify bona fide MOG~38--48~:I-A^b^ specific thymocytes. e) Representative flow cytometry plots of MOG tetramer pulldowns, concatenated from 6 thymi from wild-type mice. Left plot, number of MOG:I-A^b^ dual-tetramer^+^ T cells within the CD4^+^CD73^−^ thymocyte cell gate. Middle plot, percentage of MOG:I-A^b^ dual tetramer^+^ cells in CD25^+^T~reg~P cell, Foxp3^lo^ T~reg~P cell and T~reg~ cell gates. Right plot, cumulative data showing percentage of percentage of CD25^+^ T~reg~P cells (black squares), Foxp3^lo^ T~reg~P cells (black triangles), and Treg cells (open circles) in thymi from 15 wild-type mice. Data was analyzed by two-sided Wilcoxon matched-pairs signed rank test and is pooled from 3 independent experiments. Bars represent mean ± SD. \*P\<0.05, ns-not significant.](nihms-1514192-f0008){#F8}

###### 

List of representative TCR Vα2 CDR3 sequences and the relative read distribution in each sorted population (conventional defined as CD4^+^CD8^−^CD25^−^Foxp3^−^).

  Amino acid sequence   Reads Conventional   Read CD25^+^ T~reg~P cells   Reads Foxp3^lo^ T~reg~P cells   Reads T~reg~ cells
  --------------------- -------------------- ---------------------------- ------------------------------- --------------------
  CAASGSAGNKLTF         0                    0                            2737                            7714
  CAAKSGSFNKLTF         0                    1888                         0                               3587
  CAAKHSGTYQRF          0                    0                            1176                            3093
  CAAPSSGSWQLIF         0                    2028                         659                             1697
  CAASYYNQGKLIF         0                    349                          0                               1801
  CAASKGSNYQLIW         0                    569                          0                               1729
  CAASAPYNQGKLIF        0                    0                            4221                            1428
  CAASSSGSFNKLTF        0                    0                            1392                            1399
  CAASLDYSNNRLTL        0                    1015                         863                             1097
  CAARASGSWQLIF         0                    224                          1044                            2080
  CAAASSGSWQLIF         0                    432                          268                             1177
  CAARNYNQGKLIF         1092                 5278                         2532                            7041
  CAASGTGGYKVVF         199                  317                          2870                            1128
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